| . | TSST (N = 34) mean ± SEM (R) . | Placebo-TSST (N = 24) mean ± SEM (R) . | P . |
|---|---|---|---|
| Age (years) | 23.24 ± 0.40 (18–27) | 23.54 ± 0.51 (20–29) | .64 |
| BMI (kg/m2) | 24.23 ± 0.53 (18.37–33.19) | 23.44 ± 0.46 (20.48–28.55) | .29 |
| MAP (mmHg) | 90.91 ± 1.13 (79.56–106.78) | 94.55 ± 2.10 (71.67–111.67) | .11 |
| Plasma aldosterone (pg/mL) | 110.80 ± 12.79 (29.28–284.27) | 103.47 ± 12.81 (39.87–285.44) | .70 |
| Saliva aldosterone (pg/mL) | 93.59 ± 8.63 (49.59–204.45), n = 23 | 95.11 ± 11.72 (42.07–235.77), n = 15 | .92 |
| Plasma renin (pg/mL) | 32.43 ± 2.73 (8.16–81.04), n = 33 | 25.70 ± 3.38 (5.98–81.96) | .12 |
| Cortisol (nmol/) | 5.72 ± 0.59 (1.68–20.53) | 7.89 ± 1.33 (1.57–29.67) | .11 |
| BFI-K | n = 30 | n = 22 | |
| Extraversion | 3.62 ± 0.15 (1.75–4.75) | 3.24 ± 0.20 (2.00–5.00) | .13 |
| Agreeableness | 2.93 ± 0.13 (1.25–4.50) | 2.94 ± 0.17 (1.50–4.50) | .96 |
| Neuroticism | 2.63 ± 0.16 (1.00–4.50) | 2.38 ± 0.18 (1.25–4.25) | .30 |
| Openness | 3.58 ± 0.15 (2.20–5.00) | 3.43 ± 0.15 (2.20–4.80) | .49 |
| Conscientiousness | 3.40 ± 0.11 (1.75–4.50) | 3.49 ± 0.15 (2.25–4.75) | .62 |
| TICS-CSSS | 17.94 ± 1.63 (3–42), n = 33 | 17.38 ± 1.84 (6–40) | .82 |
| . | TSST (N = 34) mean ± SEM (R) . | Placebo-TSST (N = 24) mean ± SEM (R) . | P . |
|---|---|---|---|
| Age (years) | 23.24 ± 0.40 (18–27) | 23.54 ± 0.51 (20–29) | .64 |
| BMI (kg/m2) | 24.23 ± 0.53 (18.37–33.19) | 23.44 ± 0.46 (20.48–28.55) | .29 |
| MAP (mmHg) | 90.91 ± 1.13 (79.56–106.78) | 94.55 ± 2.10 (71.67–111.67) | .11 |
| Plasma aldosterone (pg/mL) | 110.80 ± 12.79 (29.28–284.27) | 103.47 ± 12.81 (39.87–285.44) | .70 |
| Saliva aldosterone (pg/mL) | 93.59 ± 8.63 (49.59–204.45), n = 23 | 95.11 ± 11.72 (42.07–235.77), n = 15 | .92 |
| Plasma renin (pg/mL) | 32.43 ± 2.73 (8.16–81.04), n = 33 | 25.70 ± 3.38 (5.98–81.96) | .12 |
| Cortisol (nmol/) | 5.72 ± 0.59 (1.68–20.53) | 7.89 ± 1.33 (1.57–29.67) | .11 |
| BFI-K | n = 30 | n = 22 | |
| Extraversion | 3.62 ± 0.15 (1.75–4.75) | 3.24 ± 0.20 (2.00–5.00) | .13 |
| Agreeableness | 2.93 ± 0.13 (1.25–4.50) | 2.94 ± 0.17 (1.50–4.50) | .96 |
| Neuroticism | 2.63 ± 0.16 (1.00–4.50) | 2.38 ± 0.18 (1.25–4.25) | .30 |
| Openness | 3.58 ± 0.15 (2.20–5.00) | 3.43 ± 0.15 (2.20–4.80) | .49 |
| Conscientiousness | 3.40 ± 0.11 (1.75–4.50) | 3.49 ± 0.15 (2.25–4.75) | .62 |
| TICS-CSSS | 17.94 ± 1.63 (3–42), n = 33 | 17.38 ± 1.84 (6–40) | .82 |
Abbreviations: N, total number of participants; n, number of participants in case of missing data; SEM, standard error of the mean; R, range; BMI, body mass index; MAP, mean arterial pressure; BFI-K, Big Five Inventory Short Version; CSSS, Chronic Stress Screening Scale from the Trier Inventory for Chronic Stress.
| . | TSST (N = 34) mean ± SEM (R) . | Placebo-TSST (N = 24) mean ± SEM (R) . | P . |
|---|---|---|---|
| Age (years) | 23.24 ± 0.40 (18–27) | 23.54 ± 0.51 (20–29) | .64 |
| BMI (kg/m2) | 24.23 ± 0.53 (18.37–33.19) | 23.44 ± 0.46 (20.48–28.55) | .29 |
| MAP (mmHg) | 90.91 ± 1.13 (79.56–106.78) | 94.55 ± 2.10 (71.67–111.67) | .11 |
| Plasma aldosterone (pg/mL) | 110.80 ± 12.79 (29.28–284.27) | 103.47 ± 12.81 (39.87–285.44) | .70 |
| Saliva aldosterone (pg/mL) | 93.59 ± 8.63 (49.59–204.45), n = 23 | 95.11 ± 11.72 (42.07–235.77), n = 15 | .92 |
| Plasma renin (pg/mL) | 32.43 ± 2.73 (8.16–81.04), n = 33 | 25.70 ± 3.38 (5.98–81.96) | .12 |
| Cortisol (nmol/) | 5.72 ± 0.59 (1.68–20.53) | 7.89 ± 1.33 (1.57–29.67) | .11 |
| BFI-K | n = 30 | n = 22 | |
| Extraversion | 3.62 ± 0.15 (1.75–4.75) | 3.24 ± 0.20 (2.00–5.00) | .13 |
| Agreeableness | 2.93 ± 0.13 (1.25–4.50) | 2.94 ± 0.17 (1.50–4.50) | .96 |
| Neuroticism | 2.63 ± 0.16 (1.00–4.50) | 2.38 ± 0.18 (1.25–4.25) | .30 |
| Openness | 3.58 ± 0.15 (2.20–5.00) | 3.43 ± 0.15 (2.20–4.80) | .49 |
| Conscientiousness | 3.40 ± 0.11 (1.75–4.50) | 3.49 ± 0.15 (2.25–4.75) | .62 |
| TICS-CSSS | 17.94 ± 1.63 (3–42), n = 33 | 17.38 ± 1.84 (6–40) | .82 |
| . | TSST (N = 34) mean ± SEM (R) . | Placebo-TSST (N = 24) mean ± SEM (R) . | P . |
|---|---|---|---|
| Age (years) | 23.24 ± 0.40 (18–27) | 23.54 ± 0.51 (20–29) | .64 |
| BMI (kg/m2) | 24.23 ± 0.53 (18.37–33.19) | 23.44 ± 0.46 (20.48–28.55) | .29 |
| MAP (mmHg) | 90.91 ± 1.13 (79.56–106.78) | 94.55 ± 2.10 (71.67–111.67) | .11 |
| Plasma aldosterone (pg/mL) | 110.80 ± 12.79 (29.28–284.27) | 103.47 ± 12.81 (39.87–285.44) | .70 |
| Saliva aldosterone (pg/mL) | 93.59 ± 8.63 (49.59–204.45), n = 23 | 95.11 ± 11.72 (42.07–235.77), n = 15 | .92 |
| Plasma renin (pg/mL) | 32.43 ± 2.73 (8.16–81.04), n = 33 | 25.70 ± 3.38 (5.98–81.96) | .12 |
| Cortisol (nmol/) | 5.72 ± 0.59 (1.68–20.53) | 7.89 ± 1.33 (1.57–29.67) | .11 |
| BFI-K | n = 30 | n = 22 | |
| Extraversion | 3.62 ± 0.15 (1.75–4.75) | 3.24 ± 0.20 (2.00–5.00) | .13 |
| Agreeableness | 2.93 ± 0.13 (1.25–4.50) | 2.94 ± 0.17 (1.50–4.50) | .96 |
| Neuroticism | 2.63 ± 0.16 (1.00–4.50) | 2.38 ± 0.18 (1.25–4.25) | .30 |
| Openness | 3.58 ± 0.15 (2.20–5.00) | 3.43 ± 0.15 (2.20–4.80) | .49 |
| Conscientiousness | 3.40 ± 0.11 (1.75–4.50) | 3.49 ± 0.15 (2.25–4.75) | .62 |
| TICS-CSSS | 17.94 ± 1.63 (3–42), n = 33 | 17.38 ± 1.84 (6–40) | .82 |
Abbreviations: N, total number of participants; n, number of participants in case of missing data; SEM, standard error of the mean; R, range; BMI, body mass index; MAP, mean arterial pressure; BFI-K, Big Five Inventory Short Version; CSSS, Chronic Stress Screening Scale from the Trier Inventory for Chronic Stress.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
